€30m investment ‘secures’ GSK plant

A €30m investment in a new manufacturing facility has secured the future of the GlaxoSmithKline (GSK) plant in Currabinny in Co Cork, according to site director, Finbar Whyte.

The new facility, which officially opens today, will create 20 full-time jobs and for the first time on the Cork site it will manufacture product for its consumer division.

Since the company set up in Cork in 1975 it has been a dedicated manufacturing site for pharmaceutical products. However, this division has come under huge pressure because of the ‘patent cliff’ which has seen a number of GSK products come off patent.